Get started
Sonoma Pharmaceuticals, Inc.

SNOA: $4.35 | Sold Out Shares & Under Valued

232
with new products addressing aesthetic industry should recover when volume
starts to kick in
Osang
Beyond Technical AnalysisPHARMApharmaceuticalsSNOA

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Beyond Technical AnalysisPHARMApharmaceuticalsSNOA
Osang

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.